Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 February Prevention VTE occurrence lowered by adjusting thromboprophylaxis dosages to individual anti-Xa levels Read more
2020 February Prevention BCG vaccine does not increase leukaemia or lymphoma risk, but decreases lung cancer risk Read more
Top
